| Risk factors for Toxoplasma infection in pregnancy: a case-control study in France L Baril, T Ancelle, V Goulet, P Thulliez, V Tirard-Fleury, B Carme Scandinavian journal of infectious diseases 31 (3), 305-309, 1999 | 408 | 1999 |
| Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum P Dussart, B Labeau, G Lagathu, P Louis, MRT Nunes, SG Rodrigues, ... Clinical and vaccine immunology 13 (11), 1185-1189, 2006 | 393 | 2006 |
| Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome W Liu, A Fontanet, PH Zhang, L Zhan, ZT Xin, L Baril, F Tang, H Lv, ... The Journal of infectious diseases 193 (6), 792-795, 2006 | 373 | 2006 |
| Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum P Dussart, L Petit, B Labeau, L Bremand, A Leduc, D Moua, S Matheus, ... PLoS neglected tropical diseases 2 (8), e280, 2008 | 312 | 2008 |
| Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study U Jaisamrarn, X Castellsague, SM Garland, P Naud, J Palmroth, ... PloS one 8 (11), e79260, 2013 | 189 | 2013 |
| Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study S Rachel Skinner, CM Wheeler, B Romanowski, X Castellsagué, ... International journal of cancer 138 (10), 2428-2438, 2016 | 165 | 2016 |
| Epidemiological characteristics of an urban plague epidemic in Madagascar, August–November, 2017: an outbreak report R Randremanana, V Andrianaivoarimanana, B Nikolay, ... The Lancet Infectious Diseases 19 (5), 537-545, 2019 | 124 | 2019 |
| La toxoplasmose chez la femme enceinte en France en 1995. Résultats d'une enquête nationale périnatale T Ancelle, V Goulet, V Tirard-Fleury, L Baril, C Du Mazaubrun, PH Thulliez Bulletin épidémiologique hebdomadaire 51, 227-229, 1996 | 123 | 1996 |
| Multiple organ failure complicating probable scrub typhus C Cracco, C Delafosse, L Baril, Y Lefort, C Morelot, JP Derenne, ... Clinical infectious diseases 31 (1), 191-192, 2000 | 115 | 2000 |
| Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy S Suarez, L Baril, B Stankoff, M Khellaf, B Dubois, C Lubetzki, F Bricaire, ... Aids 15 (2), 195-200, 2001 | 108 | 2001 |
| Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries SK Hollingshead, L Baril, S Ferro, J King, P Coan, DE Briles, ... Journal of medical microbiology 55 (2), 215-221, 2006 | 106 | 2006 |
| Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme MG Angelo, MP David, J Zima, L Baril, G Dubin, F Arellano, F Struyf pharmacoepidemiology and drug safety 23 (5), 466-479, 2014 | 105 | 2014 |
| Clinical and spectroscopic improvement in HIV-associated cognitive impairment B Stankoff, A Tourbah, S Suarez, E Turell, JL Stievenart, C Payan, ... Neurology 56 (1), 112-115, 2001 | 100 | 2001 |
| Long-term SARS coronavirus excretion from patient cohort, China W Liu, F Tang, A Fontanet, L Zhan, QM Zhao, PH Zhang, XM Wu, SQ Zuo, ... Emerging infectious diseases 10 (10), 1841, 2004 | 97 | 2004 |
| Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus T Li, J Xie, Y He, H Fan, L Baril, Z Qiu, Y Han, W Xu, W Zhang, H You, ... PloS one 1 (1), e24, 2006 | 95 | 2006 |
| Post‐licensure safety surveillance for human papillomavirus‐16/18‐AS04‐adjuvanted vaccine: more than 4 years of experience MG Angelo, J Zima, F Tavares Da Silva, L Baril, F Arellano pharmacoepidemiology and drug safety 23 (5), 456-465, 2014 | 92 | 2014 |
| The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study K Hampson, F Ventura, R Steenson, R Mancy, C Trotter, L Cooper, ... The Lancet Infectious Diseases 19 (1), 102-111, 2019 | 87 | 2019 |
| An In Vivo and In Vitro Model of Plasmodium falciparum Rosetting and Autoagglutination Mediated by varO, a Group A var Gene Encoding a Frequent Serotype I Vigan-Womas, M Guillotte, C Le Scanf, S Igonet, S Petres, A Juillerat, ... Infection and immunity 76 (12), 5565-5580, 2008 | 84 | 2008 |
| Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: The EVIRA project MN Niang, OM Diop, FD Sarr, D Goudiaby, H Malou‐Sompy, K Ndiaye, ... Journal of medical virology 82 (5), 866-872, 2010 | 81 | 2010 |
| Introducing new vaccines in low-and middle-income countries: challenges and approaches A Guignard, N Praet, V Jusot, M Bakker, L Baril Expert review of vaccines 18 (2), 119-131, 2019 | 80 | 2019 |
